<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04707092</url>
  </required_header>
  <id_info>
    <org_study_id>3486</org_study_id>
    <nct_id>NCT04707092</nct_id>
  </id_info>
  <brief_title>Use of Preoperative and Postoperative Antimicrobial Treatment</brief_title>
  <official_title>Use of Preoperative and Postoperative Antimicrobial Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sunnybrook Health Sciences Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sunnybrook Health Sciences Centre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, patients undergoing ear surgery (cochlear implantation, stapedotomy,&#xD;
      tympanoplasty) will be randomized to one of two antibiotic treatment groups.&#xD;
&#xD;
      One group will receive a single treatment with an antibiotic at induction&#xD;
&#xD;
      The other group will receive the single intravenous treatment, plus a one week course or oral&#xD;
      antibiotic&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Patients will be asked to participate in the study.&#xD;
&#xD;
        2. Randomization&#xD;
&#xD;
        3. Surgery&#xD;
&#xD;
        4. Follow-up at 1 week, 1 month patients will be asked if they filled their prescription,&#xD;
           took the medication as prescribed, experienced any symptoms such as rash, diarrhea,&#xD;
           nausea,.. Further the wound will be inspected for any signs of infection. Patients will&#xD;
           also be asked if they had noticed discharge, pain, pulsating sensation&#xD;
&#xD;
        5. Follow-up at three months, 1 year and 2 years - patients will again be asked for any&#xD;
           signs of infections or necessary visits with their doctor due to infections&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">June 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2022</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomization in two treatment arms</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adverse events</measure>
    <time_frame>1 month</time_frame>
    <description>Side effects from treatment with antibiotics</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Infection of surgical site (immediate)</measure>
    <time_frame>1 month</time_frame>
    <description>Infection of surgical site with discharge, redness, fever</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infection of surgical site (long term)</measure>
    <time_frame>2 years</time_frame>
    <description>infection of surgical site with discharge, fever, extrusion of device</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">304</enrollment>
  <condition>Ear Infection Bacterial</condition>
  <condition>Surgical Site Infection</condition>
  <condition>Antibiotic Side Effect</condition>
  <arm_group>
    <arm_group_label>Antibiotic at induction</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive one single dose of Antibiotic at induction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Antibiotic one week</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive one single dose of Antibiotic at induction, plus a 7 day treatment with oral Antibiotic</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Antibiotic</intervention_name>
    <description>Antibiotic in case of now allergies will be Cefazolin at induction and Amoxicillin plus Clavulanic acid for the oral treatment week</description>
    <arm_group_label>Antibiotic at induction</arm_group_label>
    <arm_group_label>Antibiotic one week</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Willing to participate in the study&#xD;
&#xD;
          -  Undergoing standard ear surgery (Stapedotomy, cochlear implantation, tympanoplasty and&#xD;
             tympanomastoidectomy)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  multiple allergies to antibiotic substances&#xD;
&#xD;
          -  therapy with an antibiotic substance within the last 6 weeks&#xD;
&#xD;
          -  prior radiation to the head and neck patients undergoing revision surgery&#xD;
&#xD;
          -  Any use of post-operative antibiotics (oral, intravenous, topical) for reason which do&#xD;
             not include surgical site infection&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Sunnybrook Health Sciences Center</name>
      <address>
        <city>Toronto</city>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>January 11, 2021</study_first_submitted>
  <study_first_submitted_qc>January 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 13, 2021</study_first_posted>
  <last_update_submitted>October 1, 2021</last_update_submitted>
  <last_update_submitted_qc>October 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Surgical Wound Infection</mesh_term>
    <mesh_term>Bacterial Infections</mesh_term>
    <mesh_term>Otitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>The individual participant data will not be shared since no conclusions can be drawn from single patient data, the results will be made available in detail</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

